DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026

· Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603233 · · 4 pages · Chinese

Summary by 6ix AI

DaShenLin Pharmaceutical Group Co., Ltd. has announced its dividend distribution plan for the first half of the year. The plan includes a cash dividend per share and outlines the relevant dates for shareholders. This filing serves to inform shareholders about the approved dividend distribution and its execution process.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603233dashenlin-pharmaceutical-group-co-ltdannouncement-on-implementation-of-dividend-distribution-for-the-first-half-of-2026

Release

Announcement on Implementation of Dividend Distribution for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Story so far

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

All DaShenLin Pharmaceutical news releases